NCT02269150View on ClinicalTrials.gov

Autologous Fecal Microbiota Transplantation (Auto-FMT) for Prophylaxis of Clostridium Difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Allogeneic Hematopoietic Stem Cell
Interventions
BIOLOGICAL

fecal microbiota transplantation (FMT)

OTHER

No fecal microbiota transplantation (FMT), routine management

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER